Thyroid Cancer Diagnostics Market Poised for Growth, Expected to Reach $3.7 Billion by 2028
Thyroid Cancer Diagnostics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033
LONDON, GREATER LONDON , UK, July 3, 2024 /EINPresswire.com/ -- The thyroid cancer diagnostics market has seen robust growth in recent years, with the market size expanding from $2.79 billion in 2023 to $2.97 billion in 2024, marking a compound annual growth rate (CAGR) of 6.2%. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. Factors driving this growth include the increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives, and improved healthcare infrastructure.
Rising Prevalence of Thyroid Cancer Driving Market Growth
Thyroid cancer diagnostics play a crucial role in early detection and treatment outcomes. The increasing prevalence of thyroid cancer, particularly in regions like North America and Asia-Pacific, is a significant driver for market expansion. For example, according to the American Cancer Society, approximately 43,720 new cases of thyroid cancer are anticipated in the United States in 2023, highlighting the pressing need for effective diagnostic solutions.
Explore the global thyroid cancer diagnostics market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=12030&type=smp
Thyroid Cancer Diagnostics Market Key Players and Market Trends
Major companies such as Pfizer Inc., General Electric, and F. Hoffmann-La Roche AG are actively involved in the thyroid cancer diagnostics market, focusing on innovative products like rearranged during transfection (RET) inhibitors. These advancements aim to cater to a larger customer base and enhance revenue streams. For instance, CStone Pharmaceuticals' approval of GAVRETO in China for managing RET-mutant medullary thyroid cancer underscores the market's focus on targeted therapies.
Thyroid Cancer Diagnostics Market Segments
The thyroid cancer diagnostics market is segmented based on:
• Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
• Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
• End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Geographical Insights: Asia-Pacific Leading Growth
North America led the thyroid cancer diagnostics market in 2023, driven by advanced healthcare infrastructure and high awareness levels. However, Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing healthcare spending and rising incidence of thyroid cancer in countries like China and India.
Make your report purchase here and explore the whole industry's data as well
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
Thyroid Cancer Diagnostics Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Thyroid Cancer Diagnostics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on thyroid cancer diagnostics market size, thyroid cancer diagnostics market drivers and trends, thyroid cancer diagnostics market major players, competitors' revenues, market positioning, and market growth across geographies. The thyroid cancer diagnostics market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report
Cancer Biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Skin Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
